Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study

BACKGROUND: Only a few patients with pancreatic ductal adenocarcinoma (PDAC) recurring after curative resection and peri-operative (neoadjuvant and adjuvant) therapy are included in clinical trials of metastatic PDAC. As such, there is a paucity of data to guide treatment after relapse, and patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Gbolahan, Olumide B., Tong, Yan, Sehdev, Amikar, O’Neil, Bert, Shahda, Safi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525379/
https://www.ncbi.nlm.nih.gov/pubmed/31101022
http://dx.doi.org/10.1186/s12885-019-5630-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525379/
https://www.ncbi.nlm.nih.gov/pubmed/31101022
http://dx.doi.org/10.1186/s12885-019-5630-4

Ejemplares similares